Halia Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-08-318/31/26 | New | $3,486,474 | $3,486,474 | Equity Only | 06b | SEC linkSEC |
| 2025-07-167/16/25 | New | $336,833 | $336,833 | Equity Only | 06b | SEC linkSEC |
| 2022-12-3012/30/22 | New | $12,223,338 | $12,223,338 | Equity Only | 06b | SEC linkSEC |
| 2021-02-172/17/21 | New | $4,999,994 | $4,999,994 | Equity Only | 06b | SEC linkSEC |
| 2020-10-2210/22/20 | New | $6,344,990 | $6,344,990 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Jared Bearss | Director |
| David Bearss | Director |
| Mary Beckerle | Director |
| Jeffrey Burton | Executive |
| Preston Campbell | Director |
| David Checketts | Director |
| John S.K. Kauwe | Director |
| Mike Mccullar | Director, Executive |
| Mike Mc Cullar | Director, Executive |
| Todd Pedersen | Director |
| Gary B. Sabin | Director |
| Jim Savas | Director |
Industry: Biotechnology (See others in industry)
Address:
3900 N. Traverse Mountain Blvd. Suite 100
Lehi, UT, 84043
Phone: 801-842-1652
Lehi, UT, 84043
Phone: 801-842-1652